Brandon E Aubol

SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo

Stephen K Burley, Spencer Emtage, Shane Atwell, 2009, Molecular Cancer Therapeutics.

Interplay between SRPK and Clk/Sty kinases in phosphorylation of the splicing factor ASF/SF2 is regulated by a docking motif in ASF/SF2.

Xiang-Dong Fu, Sutapa Chakrabarti, Xiang-Dong Fu, 2005, Molecular cell.

Processive phosphorylation of alternative splicing factor/splicing factor 2

Xiang-Dong Fu, Sutapa Chakrabarti, Jennifer Shaffer, 2003, Proceedings of the National Academy of Sciences of the United States of America.